Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Share equity incentive plans (Tables)

v3.25.0.1
Share equity incentive plans (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of options activity
The following table summarizes share option activity for the years ended December 31, 2023 and 2024:
2023 2024
Number
of
Options		 Weighted Average Exercise Price Weighted
Average Remaining Contractual Term
(in years)		 Number
of
Options		 Weighted Average Exercise Price Weighted
Average Remaining Contractual Term
(in years)
Outstanding at the beginning of the year 8,362,930  $2.28 5.25 7,351,711  $2.21 4.04
Granted —  — —  —  — — 
Exercised (863,494) 2.67  —  (2,167,781) 2.14  — 
Forfeited (147,725) 3.45  —  (39,710) 5.41  — 
Outstanding at the end of the year 7,351,711  $2.21 4.04 5,144,220  $ 2.21  3.50
Exercisable at the end of the year 6,844,376  $2.15 3.83 5,088,188  $ 2.19  3.47
Schedule of RSU activity
The following table summarizes RSU (including PRSU) activity for the years ended December 31, 2023 and 2024:
2023 2024
Number of RSUs Weighted Average Fair Value at Grant Date Number of RSUs Weighted Average Fair Value at Grant Date
Outstanding and unvested at the beginning of the year 2,866,980  $ 12.06  4,003,336  $ 8.16 
Granted 2,820,708  6.54  3,481,480  7.38 
Vested (1,060,404) 11.83  (1,524,730) 8.44 
Forfeited (623,948) 10.90  (935,132) 8.26 
Outstanding and unvested at the end of the year 4,003,336  8.16  5,024,954  7.52 
Schedule of expenses capitalized
The following table summarizes the share-based compensation recorded in each line item in the accompanying consolidated statements of comprehensive income (loss):
Year Ended December 31,
2022 2023 2024
Cost of revenue $ 599  $ 635  $ 812 
Research and development 5,287  5,782  5,511 
Sales and marketing 5,995  5,196  4,273 
General and administrative 5,106  6,514  7,019 
Total $ 16,987  $ 18,127  $ 17,615